Charles G Fisher, Tony Goldschlager, Stefano Boriani, Peter Pal Varga, Michael G Fehlings, Mark H Bilsky, Mark B Dekutoski, Alessandro Luzzati, Richard P Williams, Sigurd Berven, Dean Chou, Jeremy J Reynolds, Nasir A Quraishi, Laurence D Rhines, Chetan Bettegowda, Ziya L Gokaslan
Study Type Retrospective cohort. Introduction The treatment of rare neoplastic conditions is challenging, especially because studies providing high levels of evidence are often lacking. Such is the case with primary tumors of the spine (PTS), which have a low incidence, are pathologically heterogeneous, and have diverse treatment approaches.1 Despite these difficulties, appropriate evidence-based care of these complex patients is imperative. Failure to follow validated oncologic principles may lead to unnecessary mortality and profound morbidity...
October 2013: Evidence-based Spine-care Journal